ArticleOncology reports2025

Senescence‑associated IL‑33 secretion undermines sorafenib efficacy in hepatocellular carcinoma via immune evasion.

Yu-Xin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.